Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 3
1964 5
1965 3
1966 3
1967 5
1968 5
1969 14
1970 9
1971 13
1972 13
1973 18
1974 15
1975 11
1976 19
1977 17
1978 17
1979 20
1980 18
1981 18
1982 31
1983 40
1984 57
1985 52
1986 60
1987 58
1988 71
1989 94
1990 121
1991 116
1992 109
1993 99
1994 110
1995 118
1996 111
1997 110
1998 116
1999 113
2000 133
2001 150
2002 189
2003 194
2004 196
2005 216
2006 238
2007 256
2008 269
2009 248
2010 282
2011 289
2012 342
2013 368
2014 411
2015 461
2016 455
2017 471
2018 421
2019 432
2020 571
2021 574
2022 522
2023 482
2024 174

Text availability

Article attribute

Article type

Publication date

Search Results

9,327 results

Results by year

Filters applied: . Clear all
Page 1
Interstitial lung diseases.
Wijsenbeek M, Suzuki A, Maher TM. Wijsenbeek M, et al. Lancet. 2022 Sep 3;400(10354):769-786. doi: 10.1016/S0140-6736(22)01052-2. Epub 2022 Aug 11. Lancet. 2022. PMID: 35964592 Review.
In some conditions, spontaneous reversibility or stabilisation can occur, but unfortunately in many people with interstitial lung disease, especially in those manifesting progressive pulmonary fibrosis, respiratory failure and death are a sad reality. ...Furt …
In some conditions, spontaneous reversibility or stabilisation can occur, but unfortunately in many people with interstitial lung disease, e …
Idiopathic pulmonary fibrosis.
Richeldi L, Collard HR, Jones MG. Richeldi L, et al. Lancet. 2017 May 13;389(10082):1941-1952. doi: 10.1016/S0140-6736(17)30866-8. Epub 2017 Mar 30. Lancet. 2017. PMID: 28365056 Review.
Idiopathic pulmonary fibrosis is a prototype of chronic, progressive, and fibrotic lung disease. ...In this Seminar, we summarise the presentation, pathophysiology, diagnosis, and treatment options available for patients with idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis is a prototype of chronic, progressive, and fibrotic lung disease. ...In this Seminar, we summar …
Mechanisms of pulmonary fibrosis.
Thannickal VJ, Toews GB, White ES, Lynch JP 3rd, Martinez FJ. Thannickal VJ, et al. Annu Rev Med. 2004;55:395-417. doi: 10.1146/annurev.med.55.091902.103810. Annu Rev Med. 2004. PMID: 14746528 Free article. Review.
Significant regional heterogeneity, with varied histopathological patterns of inflammation and fibrosis, has been observed in individual patients with idiopathic pulmonary fibrosis. ...Better understanding of the mechanisms of lung repair, which include alveo …
Significant regional heterogeneity, with varied histopathological patterns of inflammation and fibrosis, has been observed in individ …
Progressive pulmonary fibrosis: an expert group consensus statement.
Rajan SK, Cottin V, Dhar R, Danoff S, Flaherty KR, Brown KK, Mohan A, Renzoni E, Mohan M, Udwadia Z, Shenoy P, Currow D, Devraj A, Jankharia B, Kulshrestha R, Jones S, Ravaglia C, Quadrelli S, Iyer R, Dhooria S, Kolb M, Wells AU. Rajan SK, et al. Eur Respir J. 2023 Mar 30;61(3):2103187. doi: 10.1183/13993003.03187-2021. Print 2023 Mar. Eur Respir J. 2023. PMID: 36517177 Free PMC article. Review.
The value of diagnostic tests in risk stratification at presentation and, separately, the importance of a logical monitoring strategy, tailored to manage the risk of progression, are also stressed. The term "progressive pulmonary fibrosis" (PPF) exactly describes th …
The value of diagnostic tests in risk stratification at presentation and, separately, the importance of a logical monitoring strategy, tailo …
Idiopathic pulmonary fibrosis.
Martinez FJ, Collard HR, Pardo A, Raghu G, Richeldi L, Selman M, Swigris JJ, Taniguchi H, Wells AU. Martinez FJ, et al. Nat Rev Dis Primers. 2017 Oct 20;3:17074. doi: 10.1038/nrdp.2017.74. Nat Rev Dis Primers. 2017. PMID: 29052582 Review.
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease characterized by progressive lung scarring and the histological picture of usual interstitial pneumonia (UIP). ...
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease characterized by progressive lung scarring and the …
Developmental pathways in the pathogenesis of lung fibrosis.
Chanda D, Otoupalova E, Smith SR, Volckaert T, De Langhe SP, Thannickal VJ. Chanda D, et al. Mol Aspects Med. 2019 Feb;65:56-69. doi: 10.1016/j.mam.2018.08.004. Epub 2018 Aug 23. Mol Aspects Med. 2019. PMID: 30130563 Free PMC article. Review.
Idiopathic pulmonary fibrosis (IPF) is a progressive and terminal lung disease with no known cure. ...In this review, we analyze current knowledge in the field, gained from both basic and clinical research, to provide new insights into the disease process, and poten …
Idiopathic pulmonary fibrosis (IPF) is a progressive and terminal lung disease with no known cure. ...In this review, we analy …
Pulmonary fibrosis, part I: epidemiology, pathogenesis, and diagnosis.
Meyer KC. Meyer KC. Expert Rev Respir Med. 2017 May;11(5):343-359. doi: 10.1080/17476348.2017.1312346. Epub 2017 Apr 10. Expert Rev Respir Med. 2017. PMID: 28345383 Review.
Many forms of interstitial lung disease (ILD) can progress to extensive fibrosis and respiratory failure. Idiopathic pulmonary fibrosis (IPF), which generally has a poor prognosis, has been thoroughly studied over the past two decades, and many importa …
Many forms of interstitial lung disease (ILD) can progress to extensive fibrosis and respiratory failure. Idiopathic pulmon
Pulmonary fibrosis: patterns and perpetrators.
Noble PW, Barkauskas CE, Jiang D. Noble PW, et al. J Clin Invest. 2012 Aug;122(8):2756-62. doi: 10.1172/JCI60323. Epub 2012 Aug 1. J Clin Invest. 2012. PMID: 22850886 Free PMC article. Review.
Pulmonary fibrosis occurs in a variety of clinical settings, constitutes a major cause of morbidity and mortality, and represents an enormous unmet medical need. ...In contrast, idiopathic pulmonary fibrosis (IPF) is a progressive and lethal form of fi
Pulmonary fibrosis occurs in a variety of clinical settings, constitutes a major cause of morbidity and mortality, and represe
Idiopathic pulmonary fibrosis.
King TE Jr, Pardo A, Selman M. King TE Jr, et al. Lancet. 2011 Dec 3;378(9807):1949-61. doi: 10.1016/S0140-6736(11)60052-4. Epub 2011 Jun 28. Lancet. 2011. PMID: 21719092 Review.
Idiopathic pulmonary fibrosis is a devastating, age-related lung disease of unknown cause that has few treatment options. ...In this Seminar, we review recent data on the clinical course, therapeutic options, and underlying mechanisms thought to be involved in the p …
Idiopathic pulmonary fibrosis is a devastating, age-related lung disease of unknown cause that has few treatment options. ...I …
Pulmonary Fibrosis as a Result of Acute Lung Inflammation: Molecular Mechanisms, Relevant In Vivo Models, Prognostic and Therapeutic Approaches.
Savin IA, Zenkova MA, Sen'kova AV. Savin IA, et al. Int J Mol Sci. 2022 Nov 29;23(23):14959. doi: 10.3390/ijms232314959. Int J Mol Sci. 2022. PMID: 36499287 Free PMC article. Review.
Pulmonary fibrosis is a chronic progressive lung disease that steadily leads to lung architecture disruption and respiratory failure. ...Despite a long history of study and good coverage of the problem in the scientific literature, the effective therapeutic a
Pulmonary fibrosis is a chronic progressive lung disease that steadily leads to lung architecture disruption and respiratory
9,327 results